The combination of TP73-AS1 targeted miRNAs was predicted from bioinformatics software Starbase, RNA22, as well as miRNAs with abnormally low expression in tumor tissues from GSE25508 and GSE51853 datasets, and were clustered by Venn investigation. Here, TP73 is linked to neoplasm.